NFKB1 and lung cancer: 20 (R)-Ginsenoside Rg3, an active monomer extracted from ginseng, might sensitize hypoxic lung cancer cells to cisplatin by blocking of NF-κB mediated epithelial-mesenchymal transition and stemness (38).